Non-Hodgkin's lymphoma after primary Hodgkin's disease in the German Hodgkin's Lymphoma Study Group: incidence, treatment, and prognosis

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
U RuefferGerman Hodgkin's Lymphoma Study Group

Abstract

The cumulative incidence for non-Hodgkin lymphoma's (NHL) after primary Hodgkin's disease (HD) ranges between 1% and 6%. To investigate the course of disease for secondary NHL, we retrospectively analyzed patients treated within clinical trials of the German Hodgkin's Lymphoma Study Group (GHSG) since 1981. From 1981 to 1998, the GHSG conducted three generations of clinical trials for the treatment of primary HD involving a total of 5,406 patients. Reference histology by an expert panel was obtained for 4,104 of the patients. Data on incidence, treatment, and outcome of secondary NHL were updated in March 1999. At first diagnosis of HD, the pathologists rejected 114 (2.1%) of 5,520 cases initially diagnosed as HD and rediagnosed them as primary NHL. Fifty-two (0.9%) of the remaining 5,406 patients developed a secondary NHL. One patient was excluded from further analyses because of insufficient documentation. Six patients had no further therapy because of patient refusal (n = 1) or rapidly progressive disease (n = 5). For the remaining 45 patients, overall response rate was 43% (36% complete response and 7% partial response). The actuarial 2-year freedom from treatment failure (FFTF) and overall survival (OS) for all patients wa...Continue Reading

References

Feb 1, 1991·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M H BennettB Vaughan Hudson
Jan 4, 1990·The New England Journal of Medicine·J M KaldorD Assouline
Aug 1, 1989·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·F E van LeeuwenA A Hart
Jan 14, 1988·The New England Journal of Medicine·M A TuckerS A Rosenberg
Jun 1, 1986·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·P ValagussaG Bonadonna
Feb 1, 1994·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·F E van LeeuwenR Somers
Sep 30, 1993·The New England Journal of Medicine·UNKNOWN International Non-Hodgkin's Lymphoma Prognostic Factors Project
Apr 30, 1994·International Journal of Radiation Oncology, Biology, Physics·G BitiV Boddi
Feb 1, 1993·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J F AbrahamsenH Høst
May 1, 1993·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·S TuraP G Gobbi
Feb 1, 1996·Annals of Oncology : Official Journal of the European Society for Medical Oncology·S J Horning
Aug 1, 1996·Annals of Oncology : Official Journal of the European Society for Medical Oncology·S A Rosenberg

❮ Previous
Next ❯

Citations

Nov 11, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Dennis A EichenauerAndreas Engert
Jul 1, 2008·Current Hematologic Malignancy Reports·Andrea K Ng
Apr 2, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Andreas JostingUNKNOWN German Hodgkin's Lymphoma Study Group
Nov 7, 2006·Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology·Michael FuchsDaniel Re
Oct 27, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Michael T MilanoLois B Travis
Feb 22, 2017·Hematological Oncology·Maria K AngelopoulouPanagiotis Tsirigotis
Aug 18, 2005·International Journal of Cancer. Journal International Du Cancer·Clara SambadeChrister Sundström
Oct 6, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Beate KlimmUNKNOWN German Hodgkin Study Group
Nov 19, 2010·Expert Review of Hematology·Andreas Josting
Jan 6, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Mubarak Al-MansourKerry J Savage
Feb 13, 2013·British Journal of Haematology·Katharine H Xing, Kerry J Savage
Apr 25, 2009·The Cancer Journal·Andrea K Ng, Peter M Mauch
Oct 20, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Karolin BehringerUNKNOWN German Hodgkin's Lymphoma Study Group
Jan 25, 2021·British Journal of Haematology·Dennis A EichenauerAndreas Engert
Oct 7, 2010·Archives of Pathology & Laboratory Medicine·Lauren B Smith
Oct 31, 2006·Annals of Oncology : Official Journal of the European Society for Medical Oncology·B KlimmUNKNOWN German Hodgkin Study Group

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.

Related Papers

Annals of Oncology : Official Journal of the European Society for Medical Oncology
Karolin BehringerGerman Hodgkin Lymphoma Study Group
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Andreas EngertGerman Hodgkin's Study Group
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Lucia NogováGerman Hodgkin Study Group
European Journal of Haematology. Supplementum
Karolin Behringer, Volker Diehl
© 2021 Meta ULC. All rights reserved